Centanafadine
id:
centanafadine-219-3528833
title:
Centanafadine
text:
Centanafadine (INN) (former developmental code name EB-1020) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that began its development with Euthymics Bioscience after they acquired DOV Pharmaceutical. It was developed as a treatment for attention-deficit hyperactivity disorder (ADHD) and inhibits the reuptake of norepinephrine, dopamine, and serotonin with an IC50 ratio of 1:6:14, respectively. In 2011, Euthymics Bioscience spun off its development of centanafadine to a new co
brand slug:
wiki
category slug:
encyclopedia
description:
Serotonin-norepinephrine-dopamine reuptake inhibitor
original url:
https://en.wikipedia.org/wiki/Centanafadine
date created:
2015-11-14T23:19:27Z
date modified:
2024-09-13T10:52:24Z
main entity:
{"identifier":"Q27276010","url":"https://www.wikidata.org/entity/Q27276010"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/ba/Centanafadine.svg","width":512,"height":536}
fields total:
13
integrity:
16